|
Click the title
below to order:
Biopharmaceuticals in the US and European Markets, 4th Edition |
Biopharmaceuticals in the
US and European Markets, 4th Edition
The only biopharmaceutical
reference! Invaluable for general, technical, and competitive information.
Includes 482 comprehensive, individual monographs, in 1,234 pages, covering
all US biotechnology products on the market, and most European products.
Provides detailed descriptions and indexing, legal, manufacturing,
competitive, marketing, technological and regulatory intelligence; It
includes unique and hard-to-find primary information.
Author: Ronald A. Rader
Publisher: BioPlan Associates, Inc, July 2005
Contents:
- Companies involved, and
relationships
- Composition, biological
and chemical aspects
- Manufacturing methods
- Patents and technology
transfer
- Regulatory history and
status
- Approved indications
- Market size and share
- Nomenclature
- Controversial aspects, and
more!
Coverage:
- Recombinant & other
proteins
- Monoclonal antibodies
- Vaccines, adjuvants
- Enzymes & toxins
- Blood products, human &
animal-derived
- Radioimmune conjugates
- Cultured cells
- Tissue products
- Antisense drugs‡And more!
New 4th Edition:
- Bigger! 1,234 pages and
482 monographs and product entries
- Better! Now includes
European/EU products;
- Indexes — 24,000+ index
entries
- Includes all US, and
European products, and many biodefense and biogeneric products
- Includes upcoming products
in 2006
- Fresh! Up-to-date into May
2005
Click the title below to order:
Biopharmaceuticals in the US and European Markets, 4th Edition |
